Related Experiment Videos
On the phosphorylation of low molecular mass HMG (high mobility group) proteins in Ehrlich ascites cells
FEBS Letters
|January 28, 1985
Abstract:
This paper shows that the low molecular mass HMG proteins 14 and 17 do not seem to be phosphorylated in Ehrlich ascites cells whereas two other small HMG proteins designated HMG I and Y are. Amino acid analysis and peptide mapping of all four proteins demonstrated that HMG I and Y were not phosphorylated modifications of HMG 14 or 17.
Insights
High mobility group (HMG) proteins 14 and 17 are not phosphorylated in cancer cells, unlike HMG proteins I and Y. Further analysis confirmed HMG I and Y are distinct proteins, not modified versions of HMG 14 or 17.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- High mobility group (HMG) proteins are involved in DNA binding and chromatin structure.
- Specific HMG proteins may play roles in cellular processes like proliferation and differentiation.
Purpose of the Study:
- To investigate the phosphorylation status of low molecular mass HMG proteins in cancer cells.
- To determine if HMG proteins I and Y are phosphorylated modifications of HMG proteins 14 and 17.
Main Methods:
- Analysis of HMG protein phosphorylation in Ehrlich ascites cells.
- Amino acid analysis of isolated HMG proteins.
- Peptide mapping of HMG proteins.
Main Results:
- HMG proteins 14 and 17 were found to be unphosphorylated.
- HMG proteins I and Y were identified as phosphorylated.
- Amino acid and peptide map analyses confirmed HMG I and Y are distinct from HMG 14 and 17.
Conclusions:
- HMG proteins 14 and 17 are not phosphorylated in Ehrlich ascites cells.
- HMG proteins I and Y are distinct phosphorylated proteins, not modifications of HMG 14 or 17.
- Differential phosphorylation of HMG proteins may indicate distinct functional roles in cancer cells.